Catalyst Wire Dossier Catalyst Wire Dossier

biphasic insulin aspart 30 formulation (current vs new)

insulin aspart protamine suspension with insulin aspart · Novo Nordisk A/S
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for biphasic insulin aspart 30 formulation (current vs new), covering 2017-01-06 to 2017-01-06. Get the full timeline:

Most recent: Clinical Trial Update: Comparison of Two Biphasic Insulin Aspart 30 Formulations (Current and New Formulation) in Healthy Volunteers [Phase 1]

See pricing